Recent cannabis use and myocardial infarction in young adults: a cross-sectional study
- PMID: 34493564
- PMCID: PMC8443297
- DOI: 10.1503/cmaj.202392
Recent cannabis use and myocardial infarction in young adults: a cross-sectional study
Abstract
Background: Cannabis use is increasing among young adults, but its effects on cardiovascular health are poorly understood. We aimed to assess the association between recent cannabis use and history of myocardial infarction (MI) in young adults (aged 18-44 yr).
Methods: We performed a cross-sectional study using pooled data from the 2017 and 2018 cohorts of the American Behavioral Risk Factor Surveillance System survey of US adults. We analyzed the association between any recent cannabis use and history of MI using a weighted logistic regression model that adjusted for demographic factors, socioeconomic factors, health-related behaviours, concomitant substance use and other comorbidities. We also assessed this association after stratifying by frequency of use and by primary method of consumption.
Results: Among 33 173 young adults (18.5 million weighted), 4610 respondents (3.2 million weighted) reported recent cannabis use (17.5%, 95% confidence interval [CI] 16.8%-18.2%). A history of MI was more frequent among recent cannabis users (n = 61 of 4610, 1.3%) relative to nonusers (n = 240 of 28 563 [0.8%], adjusted odds ratio [OR] 2.07, 95% CI 1.12-3.82). A history of MI was associated with cannabis use of more than 4 times per month (adjusted OR 2.31, 95% CI 1.18-4.50), and with smoking as a primary method of consumption (adjusted OR 2.01, 95% CI 1.02-3.98).
Interpretation: Our study provides evidence supporting an association between recent cannabis use and history of MI in young adults. Increasing cannabis use in an at-risk population could have negative implications for cardiovascular health.
© 2021 CMA Joule Inc. or its licensors.
Conflict of interest statement
Competing interests: Karim Ladha and Hance Clarke are principal investigators of an observational medical cannabis study funded by Shoppers Drug Mart. Subodh Verma is President of the Canadian Medical and Surgical Knowledge Translation Research Group, a federally incorporated not-for-profit physician organization, and reports research grants and/or speaking honoraria from Boehringer Ingelheim, Eli Lilly, AstraZeneca, Janssen, Merck, Novartis, Novo Nordisk, Amgen, Sanofi, Servier, Sun Pharmaceuticals, HLS Therapeutics, Amarin, Valeant, Bayer, PhaseBio and Pfizer. C. David Mazer reports consulting fees from Amgen, AstraZeneca, Boehringer Ingelheim and Octapharma. No other competing interests were declared.
Figures
Comment in
-
Pediatric cannabis use and cardiac complications.CMAJ. 2021 Nov 15;193(45):E1737. doi: 10.1503/cmaj.80288. CMAJ. 2021. PMID: 34782379 Free PMC article. No abstract available.
Similar articles
-
Associations Between Monthly Cannabis Use and Myocardial Infarction in Middle-Aged Adults: NHANES 2009 to 2018.Am J Cardiol. 2023 Oct 1;204:226-233. doi: 10.1016/j.amjcard.2023.07.065. Epub 2023 Aug 7. Am J Cardiol. 2023. PMID: 37556891 Free PMC article.
-
Marijuana Use Among Young Adults (18-44 Years of Age) and Risk of Stroke: A Behavioral Risk Factor Surveillance System Survey Analysis.Stroke. 2020 Jan;51(1):308-310. doi: 10.1161/STROKEAHA.119.027828. Epub 2019 Nov 11. Stroke. 2020. PMID: 31707926
-
Sociodemographic Characteristics Associated With and Prevalence and Frequency of Cannabis Use Among Adults in the US.JAMA Netw Open. 2021 Nov 1;4(11):e2136571. doi: 10.1001/jamanetworkopen.2021.36571. JAMA Netw Open. 2021. PMID: 34846523 Free PMC article.
-
Cannabis use and atherosclerotic cardiovascular disease outcomes: A meta-analysis of multinational cohort data.Dis Mon. 2025 Mar;71(3):101849. doi: 10.1016/j.disamonth.2024.101849. Epub 2025 Jan 11. Dis Mon. 2025. PMID: 39800612
-
Cerebrovascular Complications Associated with Marijuana Use.Curr Neurol Neurosci Rep. 2021 Apr 7;21(6):25. doi: 10.1007/s11910-021-01113-2. Curr Neurol Neurosci Rep. 2021. PMID: 33825077 Review.
Cited by
-
Association of Cannabis Use With Cardiovascular Outcomes Among US Adults.J Am Heart Assoc. 2024 Mar 5;13(5):e030178. doi: 10.1161/JAHA.123.030178. Epub 2024 Feb 28. J Am Heart Assoc. 2024. PMID: 38415581 Free PMC article.
-
Prevalence and association of non-medical cannabis use with post-procedural healthcare utilisation in patients undergoing surgery or interventional procedures: a retrospective cohort study.EClinicalMedicine. 2023 Jan 31;57:101831. doi: 10.1016/j.eclinm.2023.101831. eCollection 2023 Mar. EClinicalMedicine. 2023. PMID: 36798752 Free PMC article.
-
Considerations for Anesthesia in Older Adults with Cannabis Use.Drugs Aging. 2024 Dec;41(12):933-943. doi: 10.1007/s40266-024-01161-6. Epub 2024 Dec 1. Drugs Aging. 2024. PMID: 39617807 Review.
-
Serum Metabolomic Analysis of Male Patients with Cannabis or Amphetamine Use Disorder.Metabolites. 2022 Feb 14;12(2):179. doi: 10.3390/metabo12020179. Metabolites. 2022. PMID: 35208253 Free PMC article.
-
Associations Between Monthly Cannabis Use and Myocardial Infarction in Middle-Aged Adults: NHANES 2009 to 2018.Am J Cardiol. 2023 Oct 1;204:226-233. doi: 10.1016/j.amjcard.2023.07.065. Epub 2023 Aug 7. Am J Cardiol. 2023. PMID: 37556891 Free PMC article.
References
-
- World Drug Report. Geneva: World Health Organization; 2018. Available: https://www.unodc.org/wdr2018/ (accessed 2020 Oct. 15).
-
- Cannabis legalization and regulation. Ottawa: Government of Canada, Department of Justice; 2018. Available: https://www.justice.gc.ca/eng/cj-jp/cannabis/ (accessed 2020 Oct. 15).
-
- Hartman M. Cannabis overview: legalization. Denver and Washington (D.C.): National Conference of State Legislatures; 2019. Available: https://www.ncsl.org/research/civil-and-criminal-justice/marijuana-overv... (accessed 2020 Oct. 15).
-
- Rotermann MJHR. Analysis of trends in the prevalence of cannabis use and related metrics in Canada. Health Rep 2019;30:3–13. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical